Table 1. Baseline demographics and clinical characteristics.
| N=49 | |
|---|---|
|
Age, years | |
| Median (range) |
63.4 (43–82) |
|
Gender, n (%) | |
| Male | 37 (76) |
| Female |
12 (24) |
|
ECOG performance status, n (%)a | |
| 0 | 30 (61) |
| 1 |
18 (37) |
|
Primary tumor, n (%) | |
| Colon | 29 (59) |
| Rectum |
20 (41) |
|
(Neo) adjuvant therapy, n (%) | |
| Yes | 15 (30) |
| No |
34 (70) |
|
Metastatic sites, n (%) | |
| 1 | 12 (24) |
| ⩾2 |
37 (76) |
|
Risk group, n (%)b | |
| Low (0–2 points) | 45 (92) |
| High (3–4 points) | 3 (6) |
Abbreviation: ECOG=Eastern Cooperative Oncology Group.
a
ECOG performance status was unknown in one patient (2%).
b
Based on the risk groups defined by Köhne et al (2002); assessment is missing in one patient (2%).